AustinPx, Pharmaceutics and Manufacturing

The decision makers in AustinPx, Pharmaceutics and Manufacturing are Chris Brough, Collin Burger, Justin Keen, etc. Click to Find AustinPx, Pharmaceutics and Manufacturing decision makers emails.

AustinPx specializes in providing comprehensive services to drug developers, focusing on enhancing the bioavailability and solubility of drug candidates. Our offerings include contract development and manufacturing organization (CDMO) services, formulation development, solid-state characterization, and the innovative KinetiSol™ technology for amorphous solid dispersions. We aim to support clients throughout the drug development process, from initial formulation to final manufacturing.

KinetiSol™ technology is a proprietary process developed by AustinPx that enhances the solubility and bioavailability of poorly soluble compounds. This technology utilizes a unique combination of mechanical and thermal energy to create amorphous solid dispersions, which can significantly improve the dissolution rates of active pharmaceutical ingredients (APIs). By using KinetiSol™, developers can overcome common formulation challenges and increase the likelihood of successful drug development.

AustinPx serves a variety of industries within the pharmaceutical sector, including small molecule pharmaceuticals, biotechnology, and specialty pharmaceuticals. Our expertise in solubility enhancement and drug formulation makes us a valuable partner for companies looking to develop innovative therapies across different therapeutic areas, such as oncology, neurology, and infectious diseases.

Yes, AustinPx can assist clients with regulatory submissions by providing the necessary documentation and data to support the approval process. Our team is experienced in preparing regulatory submissions and can help ensure that all required information regarding formulation, manufacturing processes, and stability studies is accurately compiled and presented to regulatory agencies. This support is crucial for clients aiming to bring their drug candidates to market efficiently.

Solid-state characterization is the process of analyzing the physical and chemical properties of solid drug substances. This includes understanding their crystalline or amorphous forms, polymorphism, and stability. At AustinPx, we conduct thorough solid-state characterization to ensure that drug candidates maintain their efficacy and stability throughout the development process. This is essential for predicting how a drug will behave in the body and ensuring consistent manufacturing quality.

To get started with AustinPx, you can visit our website at http://www.austinpx.com and fill out the contact form to request a consultation. Our team will reach out to discuss your specific needs and how our services can support your drug development project. We encourage potential clients to provide as much detail as possible about their drug candidates and any challenges they are facing, so we can tailor our approach to meet their requirements effectively.